Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Refractory or Relapsed Aggressive r/r B-NHL With Huge Tumor Burden × Decitabine × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 50 Myelodysplastic Syndromes 30 Leukemia 17 Leukemia, Myelomonocytic, Chronic 11 Recurrence 4 Neoplasms 4 Leukemia, Monocytic, Acute 4 Congenital Abnormalities 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Myeloproliferative Disorders 3 Melanoma 3 Leukemia, Myelomonocytic, Acute 3 Leukemia, Megakaryoblastic, Acute 3 Leukemia, Erythroblastic, Acute 3 Carcinoma, Non-Small-Cell Lung 3 Neoplasm Metastasis 2 Lung Neoplasms 2 Carcinoma, Renal Cell 2 Breast Neoplasms 2 Anemia, Refractory, with Excess of Blasts 2 Anemia, Refractory 2 Triple Negative Breast Neoplasms 1 Thrombocytopenia 1 Thrombocythemia, Essential 1 Skin Neoplasms 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Ovarian Neoplasms 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡